MICHAEL DEFABRIZIO: Open Payments
NPI 1568013175 · PROVINCETOWN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$765 in 22 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $254 · 2025 $765
Food & beverage: $753Education: $12
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 14 | $476 |
| Novo Nordisk Inc | 1 | $125 |
| ViiV Healthcare Company | 2 | $63 |
| Alkermes, Inc. | 1 | $29 |
| Exact Sciences Corporation | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Amgen Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
Products named: Biktarvy, Ozempic, APRETUDE, Yeztugo, VIVITROL, The Cologuard Plus Collection Kit, LEQVIO, OTEZLA.
Industry payments across MA — which companies pay providers there.
